Drug Trial Radar · NCT00269568
Mifepristone at Same Time Multicenter Study
Last checked: Nov 20, 2026Latest source record: Jan 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,128
Actual
Start
Jun 2004
Primary completion
Apr 2006
Study completion Apr 2006
Sponsor
- Lead sponsor
- University of PittsburghAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 23, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized study. 564 healthy women, age 18 years or older, with an intrauterine pregnancy, and requesting a medical abortion, will be recruited to participate in this prospective clinical trial. This study will provide an evaluation of oral mifepristone 200 mg and vaginal misoprostol 800 mcg administered simultaneously in women up to 63 days gestation. The aims of the study are to compare the complete abortion rates, at 7 and 14 days after misoprostol administration, when using mifepristone 200 mg orally and misoprostol 800 mcg vaginally are administered simultaneously and 24 hours apart in women up to 63 days gestation. Assessment of side effects (nausea, vomiting, pain) as well as acceptability will be done using pre and post-study questionnaires, and visual analogue scales. Complete abortion rate within 24 hours is expected to be 90%
Conditions
- Abortion Seekers
Interventions
mifepristone and misoprostolDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- complete abortion rateTime frame: 5 weeks after treatment
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of Southern California
Los Angeles, California
Northwestern University
Chicago, Illinois
Oregon Health Sciences University
Portland, Oregon
Magee-Womens Hospital
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.